As adjuvant therapy for breast cancer has become more generally used, there seems to be a decreased need for prognostic factors. Nonetheless it remains a challenge to predict which patients are at ...

These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...

Cancer-specific antigens and antibodies are successfully employed as Tumor markers. Carcinoembryonic Antigen (CEA) is a cancer-specific protein that is also used as a tumor marker. The CEA was one of ...

Researchers were surprised to find that dogs and humans share a common tumor marker. The researchers uncovered a molecule, the CEA (carcinoembryonic antigen) receptor, that is almost identical in the ...

A phase I study of amrubicin and carboplatin for previously untreated patients with extensive stage small-cell lung cancer No significant financial relationships to disclose. This is an ASCO Meeting ...

Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...

“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...

Please provide your email address to receive an email when new articles are posted on . Elevated postoperative serum carcinoembryonic antigen increased risk for recurrence, especially within the first ...

ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska Over a 1-year period, the mean ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...